TrumpRx.gov Launches to Offer Lower Prescription Drug Prices for Americans
President Trump has introduced TrumpRx.gov, a new platform aimed at reducing the cost of prescription drugs for Americans by leveraging pricing agreements with major pharmaceutical companies. The site allows consumers to purchase 40 popular and typically expensive medications at prices comparable to those in other developed countries, known as most-favored-nation (MFN) prices. For instance, the monthly cost of medications like Ozempic and Wegovy, which are used for diabetes and weight management, will drop significantly from over $1,000 to as low as $199, depending on the dosage. The initiative involves partnerships with pharmaceutical giants such as AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with plans to expand the list of available drugs in the future. GoodRx is a key partner, providing integrated pricing for Pfizer's medications on the platform.